Ferenc Lakosi
Papers
2
Total Citations
39
H-Index
2
About
Ferenc Lakosi is a leading figure in the field of stereotactic body radiotherapy (SBRT), with a focused expertise in treating hepatic and pulmonary malignancies using robotic radiosurgery. His major contributions center on demonstrating the clinical efficacy and safety of CyberKnife-based SBRT for challenging patient populations. In his landmark 2017 study on unresectable hepatic oligorecurrence, Lakosi established that robotic SBRT offers a potent, non-invasive salvage option, achieving high local control with minimal toxicity for patients with limited liver metastases. This work, cited 20 times, has helped define treatment paradigms for oligometastatic disease. Complementing this, his comprehensive analysis of 130 patients with primary and secondary lung tumors—cited 19 times—provided robust evidence that CyberKnife SBRT yields excellent outcomes across a spectrum of lung lesions, from early-stage primary cancers to recurrent and metastatic nodules. By systematically reporting on these large, real-world cohorts, Lakosi has significantly advanced the clinical integration of robotic SBRT, offering a precise and effective alternative to surgery for inoperable patients. His work remains a cornerstone for radiation oncologists seeking to optimize non-surgical management of thoracic and abdominal tumors.
Research Focus
Key Achievements
Top Papers
- 1
- 2